|
|
Volumn 361, Issue 1, 2009, Pages 93-95
|
|
Rosuvastatin in patients undergoing hemodialysis [6]
a
a
INSCOL Hospital
(India)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
ROSUVASTATIN;
FLUOROBENZENE;
PYRIMIDINE DERIVATIVE;
SULFONAMIDE;
PHOSPHORUS;
BLOOD VESSEL CALCIFICATION;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR RISK;
HEART LEFT VENTRICLE HYPERTROPHY;
HEART PROTECTION;
HEMODIALYSIS;
HUMAN;
HYPERHOMOCYSTEINEMIA;
LETTER;
MORTALITY;
PRIORITY JOURNAL;
AGE;
CHRONIC KIDNEY FAILURE;
NOTE;
RENAL REPLACEMENT THERAPY;
RISK FACTOR;
TREATMENT OUTCOME;
BLOOD;
EPIDEMIOLOGY;
HYPERPHOSPHATEMIA;
CLINICAL RESEARCH;
KIDNEY FAILURE;
AGE FACTORS;
CARDIOVASCULAR DISEASES;
FLUOROBENZENES;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
KIDNEY FAILURE, CHRONIC;
PYRIMIDINES;
RENAL DIALYSIS;
RISK FACTORS;
SULFONAMIDES;
TREATMENT OUTCOME;
CONFOUNDING FACTORS (EPIDEMIOLOGY);
HYPERPHOSPHATEMIA;
HYPERTROPHY, LEFT VENTRICULAR;
PHOSPHORUS;
|
|
EID: 67649672282
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMc090901 Document Type: Letter |
|
Times cited : (1)
|
|
References (4)
|
